Rothaus Plastic Surgery is pleased to announce that we are one of the first of an exclusive group of providers to offer DAXXIFY™. DAXXIFY™ is an FDA approved neuromodulator that provides long-lasting efficacy using peptide powered technology for treatment of facial lines associated with aging and frowning.

Call our offices in Manhattan or Westchester today to book your appointment.


DAXXIFY™ is FDA approved to help smooth moderate to severe lines between the brows. DAXXIFY™’s active ingredient is botulinum toxin type A which has been used for frown line treatments for decades.

The experience to this time with conventional injectables is results that last 3-4 months and require multiple treatments a year in order to keep a smooth appearance. What makes DAXXIFY™ different is that it is powered by a protein which gives results that last an average of 6 months and up to 9 months.

Almost 9 out of 10 patients say they wish that their injectable results lasted longer. With DAXXIFY™ you can keep those smoother results for a full year with as few as 2 treatments.

Call our office today to book your appointment.


All neuromodulators require a special ingredient known as an excipient to stabilize botulinum toxin A. Botox™ uses HSA or human serum albumin. Dysport™ uses HSA as a stabilizer and a milk protein as a protectant.

DAXXIFY™ is unique because it uses a novel peptide as a stabilizer and does not contain any human or animal byproducts. In addition, DAXXIFY™ is the only neuromodulator that is made in the USA!

Call our office today to book your appointment.


DAXXIFY™ was investigated in the biggest study every conducted for a product to treat frown lines. There were more than 2400 patients in the study encompassing different ages and skin types. Some of the key points from the study are:

  1. 1. No serious side effects
  2. 2. Longer lasting results
  3. 3. 96% patient satisfaction

Call our office today to book your appointment.